ID   HLY-1
AC   CVCL_H207
SY   HLY1
DR   Cosmic; 1486589
DR   GEO; GSM1035337
DR   GEO; GSM1374539
DR   Wikidata; Q54889870
RX   PubMed=15122589;
RX   PubMed=18077790;
RX   PubMed=21179087;
CC   From: Al Saati, Talal; Hopital de Purpan, Centre Hospitalier Universitaire de Toulouse; Toulouse; France.
CC   Sequence variation: Mutation; HGNC; 7562; MYD88; Simple; p.Ser206Cys (c.617C>G) (p.Ser219Cys, c.656C>G) (S219C); Zygosity=Heterozygous (PubMed=21179087).
CC   Omics: Transcriptome analysis by microarray.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
RX   PubMed=15122589; DOI=10.1002/ijc.20170;
RA   Liggins A.P., Guinn B.A., Hatton C.S., Pulford K., Banham A.H.;
RT   "Serologic detection of diffuse large B-cell lymphoma-associated
RT   antigens.";
RL   Int. J. Cancer 110:563-569(2004).
//
RX   PubMed=18077790; DOI=10.1182/blood-2007-09-115113;
RA   Brown P.J., Ashe S.L., Leich E., Burek C., Barrans S., Fenton J.A.,
RA   Jack A.S., Pulford K., Rosenwald A., Banham A.H.;
RT   "Potentially oncogenic B-cell activation-induced smaller isoforms of
RT   FOXP1 are highly expressed in the activated B cell-like subtype of
RT   DLBCL.";
RL   Blood 111:2816-2824(2008).
//
RX   PubMed=21179087; DOI=10.1038/nature09671; PMCID=PMC5024568;
RA   Ngo V.N., Young R.M., Schmitz R., Jhavar S., Xiao W.-M., Lim K.-H.,
RA   Kohlhammer H., Xu W.-H., Yang Y.-D., Zhao H., Shaffer A.L. 3rd,
RA   Romesser P.B., Wright G., Powell J.I., Rosenwald A.,
RA   Muller-Hermelink H.-K., Ott G., Gascoyne R.D., Connors J.M.,
RA   Rimsza L.M., Campo E., Jaffe E.S., Delabie J., Smeland E.B.,
RA   Fisher R.I., Braziel R.M., Tubbs R.R., Cook J.R., Weisenburger D.D.,
RA   Chan W.-C., Staudt L.M.;
RT   "Oncogenically active MYD88 mutations in human lymphoma.";
RL   Nature 470:115-119(2011).
//